Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
5 Leser
Artikel bewerten:
(0)

DIAGEO PLC - Director/PDMR Shareholding

TO:       Regulatory Information Service

          PR Newswire

RE:       PARAGRAPH 3.1.4 OF THE DISCLOSURE AND TRANSPARENCY RULES

The notifications listed below were all received under Paragraph 3.1.2 of the
Disclosure and Transparency Rules.

Diageo plc (the "Company") announces that:

 1. It received notification on 10 September 2014 of the following allocations
    of ordinary shares of 28 101/108 pence each in the Company ("Ordinary
    Shares") under the Diageo Share Incentive Plan (the "Plan"), namely:

(i) the following director of the Company was allocated Ordinary Shares on 10
September 2014 under the Plan, by Diageo Share Ownership Trustees Limited (the
"Trustee"):

Name of Director              Number of Ordinary Shares

D Mahlan                      11

(ii) the following Persons Discharging Managerial Responsibilities ("PDMR")
were allocated Ordinary Shares on 10 September 2014 under the Plan, by the
Trustee:

Name of PDMR                 Number of Ordinary Shares

N Blazquez                   11

S Moriarty                   11

L Wood                       10

The number of Ordinary Shares allocated comprises those purchased on behalf of
the employee using an amount which the employee has chosen to have deducted
from salary ("Sharepurchase") and those awarded to the employee by the Company
("Sharematch") on the basis of one Sharematch Ordinary Share for every two
Sharepurchase Ordinary Shares.

The Sharepurchase Ordinary Shares were purchased and the Sharematch Ordinary
Shares were awarded at a price per share of £18.31.

The Ordinary Shares are held by the Trustee and in the name of the Trustee.
Sharepurchase Ordinary Shares can normally be sold at any time. Sharematch
Ordinary Shares cannot normally be disposed of for a period of three years
after the award date.

 2. It received notification on 10 September 2014 that Dr FB Humer, a director
    of the Company, had purchased 453 Ordinary Shares on 10 September 2014
    under an arrangement with the Company, whereby he has agreed to use an
    amount of £8,000 each month, net of tax, from his director's fees to
    purchase Ordinary Shares. Dr Humer has agreed to retain the Ordinary Shares
    while he remains a director of the Company.

The Ordinary Shares were purchased at a price per share of £18.31.

As a result of the above transactions, interests of directors and PDMRs in the
Company's Ordinary Shares and American Depository Shares ("ADS")* (excluding
options, awards under the Company's LTIPs and interests as potential
beneficiaries of the Company's Employee Benefit Trusts) are as follows:

Name of Director             Number of Ordinary Shares

Dr FB Humer                  54,571

D Mahlan                     228,707 (of which 137,249 are held as
                             ADS)*

Name of PDMR                 Number of Ordinary Shares

N Blazquez                   68,614

S Moriarty                   36,310

L Wood                       2,589


C Matthews

Assistant Secretary

10 September 2014

*1 ADS is the equivalent of 4 Ordinary Shares.
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.